Schedule III - Supplementary Insurance Information

12 Months Ended

Dec. 31, 2012

Notes

Schedule III - Supplementary Insurance Information

SCHEDULE III

AMERICAN INDEPENDENCE CORP. AND SUBSIDIARIES

SUPPLEMENTARY INSURANCE INFORMATION

(In thousands)

										INSURANCE		SELLING,
										BENEFITS,		GENERAL
								NET		CLAIMS		AND		NET
		INSURANCE		UNEARNED		PREMIUMS		INVESTMENT		AND		ADMINISTRATIVE		PREMIUMS
		RESERVES		PREMIUMS		EARNED		INCOME (1)		RESERVES		EXPENSES (2)		WRITTEN
DECEMBER 31, 2012:
Independence American:
Medical stop-loss	$	16,363	$	-	$	47,531	$	1,327	$	32,574	$	12,924	$	47,531
Fully Insured Health		7,822		2,224		32,762		513		22,220		7,784		34,699
Group Disability		808		213		3,485		65		2,055		1,043		3,557
Total Independence American		24,993		2,437		83,778		1,905		56,849		21,751		85,787
Risk Solutions and Agencies		-		-		-		171		-		14,705		-
Corporate		-		-		-		50		-		1,419		-
Total	$	24,993	$	2,437	$	83,778	$	2,126	$	56,849	$	37,875	$	85,787
DECEMBER 31, 2011:
Independence American:
Medical stop-loss	$	14,165	$	-	$	38,569	$	1,417	$	25,759	$	11,497	$	38,569
Fully Insured Health		6,259		287		30,913		496		20,198		6,935		31,188
Group Disability		606		140		2,966		68		1,811		917		2,987
Total Independence American		21,030		427		72,448		1,981		47,768		19,349		72,744
Risk Solutions and Agencies		-		-		-		163		-		13,737		-
Corporate		-		-		-		45		-		1,838		-
Total	$	21,030	$	427	$	72,448	$	2,189	$	47,768	$	34,924	$	72,744
DECEMBER 31, 2010:
Independence American:
Medical stop-loss	$	15,089	$	-	$	39,247	$	1,683	$	28,789	$	10,923	$	39,247
Fully Insured Health		6,272		11		31,394		508		19,568		7,725		31,376
Group Disability		648		120		3,218		75		1,869		936		3,218
Total Independence American		22,009		131		73,859		2,266		50,226		19,584		73,841
Risk Solutions and Agencies		-		-		-		236		-		13,071		-
Corporate		-		-		-		16		-		1,589		-
Total	$	22,009	$	131	$	73,859	$	2,518	$	50,226	$	34,244	$	73,841

(1)           Net investment income is allocated between product lines based on the mean reserve method.

(2)           Where possible, direct operating expenses are specifically identified and charged to product lines. Indirect expenses are allocated based on time studies; however, other acceptable methods of allocation might produce different results.